WST
WEST PHARMACEUTICAL SERVICES INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$383.91
−0.03%Year over year
Reported trailing growth
- Revenue
- +12.4%
- EBITDA
- +14.5%
- EBIT
- +9.8%
- EPS
- +17.1%
- Free cash flow
- +27.0%
- Operating cash flow
- -2.1%
Forward estimates
Based on analyst estimates
- Revenue
- +4.8%
- EBITDA
- +19.6%
- EPS
- +22.3%
Three-year CAGR
- Revenue
- +2.1%
- EBITDA
- -1.6%
- EBIT
- -6.8%
- Net income
- -5.5%
- EPS
- -4.7%
- Free cash flow
- +2.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026